Oncology-focused digital therapeutics firm Mika Well being introduced a partnership with pharma firms AstraZeneca and Daiichi Sankyo for an initiative dubbed “UNITE” to offer digital therapeutics to ladies present process breast most cancers remedies.
Mika Well being’s app provides most cancers sufferers entry to psychological help to cut back disease-related anxiousness, despair and stress. Sufferers can monitor unwanted side effects from drugs, obtain remedy reminders, get hold of schooling and vitamin recommendation, and coordinate appointments.
The digital therapeutic, already licensed as a medical system and launched within the EU, might be personalised to a person’s particular sort of most cancers.
By means of the partnership, Mika Well being’s choices will probably be used alongside pharmaceutical remedy.
German-speaking sufferers in Switzerland can first entry the providing, after which the businesses will broaden to incorporate Switzerland’s French- and Italian-speaking areas.
“Digital therapies have gotten more and more vital in trendy most cancers therapy,” Adam Nosal, head of oncology at AstraZeneca Switzerland, mentioned in an announcement. “This partnership with Mika permits us to broaden entry to holistic most cancers care and achieve insights that can form our broader efforts to enhance therapeutic choices for most cancers sufferers.”
THE LARGER TREND
In June, Mika Well being and the worldwide nonprofit Most cancers Assist Group introduced they’ll present an AI-enabled oncology-focused digital therapeutic for U.S.-based most cancers sufferers and their caregivers to entry psychological well being and different help companies freed from cost.
Earlier this yr, the corporate introduced a partnership with AI oncology agency Huge Bio to offer free entry to Miko’s choices by way of Huge Bio’s platform.
Mika sufferers would even be given the power to take part in Huge’s AI-enabled biomarker testing and scientific trial matching choices.
The HIMSS AI in Healthcare Discussion board is scheduled to happen September 5-6 in Boston. Be taught extra and register.
